Ikhui Kho
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ikhui Kho has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Afitz Da Silva
IBMM, University of Montpellier, CNRS, ENSCM, 34293 Montpellier, France
1 shared publication Aleksander Hinek
Hospital for Sick Children Research Institute, Toronto, ON, Canada
1 shared publication- Alexey V. Pshezhetsky
CHU Sainte-Justine Research Center, Université de Montréal, Montreal, H3T 1C5, QC, Canada
1 shared publication - Angela Messina
CNR—Institute for Polymers, Composites and Biomaterials (IPCB), 95126 Catania, Italy
1 shared publication - Benjamin Ellezam
Division of Pathology, CHU Sainte-Justine, Department of Pathology and Cell Biology, Université de Montréal, Montréal, Québec, Canada
1 shared publication - Carlos Ramon Morales
Affiliation Department of Anatomy and Cell Biology, McGill University, Montreal, Quebec, Canada
1 shared publication
Latest Publications
- Open Access
- 30 June 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (26) , eade6308
N -acetylneuraminate pyruvate lyase controls sialylation of muscle glycoproteins essential for muscle regeneration and function
Deleterious variants in N- acetylneuraminate pyruvate lyase (NPL) cause skeletal myopathy and cardiac edema in humans and zebrafish, but its physiological role remains unknown. We report generation of mouse models of the disease: Npl R63C , carrying the human p.Arg63Cys variant, and Npl del116 with a 116-bp exonic deletion. In both strains, NPL deficiency causes drastic increase in free sialic acid levels, reduction of skeletal muscle force and endurance, slower healing and smaller size of newly formed myofibers after cardiotoxin-induced muscle injury, increased glycolysis, partially impaired mitochondrial function, and aberrant sialylation of dystroglycan and mitochondrial LRP130 protein. NPL-catalyzed degradation of sialic acid in the muscle increases after fasting and injury and in human patient and mouse models with genetic muscle dystrophy, demonstrating that NPL is essential for muscle function and regeneration and serves as a general marker of muscle damage. Oral administration of N- acetylmannosamine rescues skeletal myopathy, as well as mitochondrial and structural abnormalities in Npl R63C mice, suggesting a potential treatment for human patients.
- 30 June 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (26) , eade6308
Open AccessN -acetylneuraminate pyruvate lyase controls sialylation of muscle glycoproteins essential for muscle regeneration and function
Deleterious variants in N- acetylneuraminate pyruvate lyase (NPL) cause skeletal myopathy and cardiac edema in humans and zebrafish, but its physiological role remains unknown. We report generation of mouse models of the disease: Npl R63C , carrying the human p.Arg63Cys variant, and Npl del116 with a 116-bp exonic deletion. In both strains, NPL deficiency causes drastic increase in free sialic acid levels, reduction of skeletal muscle force and endurance, slower healing and smaller size of newly formed myofibers after cardiotoxin-induced muscle injury, increased glycolysis, partially impaired mitochondrial function, and aberrant sialylation of dystroglycan and mitochondrial LRP130 protein. NPL-catalyzed degradation of sialic acid in the muscle increases after fasting and injury and in human patient and mouse models with genetic muscle dystrophy, demonstrating that NPL is essential for muscle function and regeneration and serves as a general marker of muscle damage. Oral administration of N- acetylmannosamine rescues skeletal myopathy, as well as mitochondrial and structural abnormalities in Npl R63C mice, suggesting a potential treatment for human patients.